AVEFF.US Avecho Biotechnology Limited

Healthcare Biotechnology USA Stocks
0.0045 USD
Close of Sep 19, 2026
0.0045 0.0045
Market cap
USD 17.4M
P/E
-
P/B
1.33x
ROE
-403.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is AVEFF.US undervalued?

Graham number

The Graham number of Avecho Biotechnology Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Avecho Biotechnology Limited fundamental analysis

No fundamental analysis for Avecho Biotechnology Limited yet.

Avecho Biotechnology Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Avecho Biotechnology Limited

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical produc…

Full company profile